Effects of Hormonal Contraceptives on Intraocular Pressure: Implications for Patients at Risk of Glaucoma
PDF (Português (Brasil))

Keywords

Intraocular pressure; Hormonal contraceptives; Glaucoma.

How to Cite

Villamarim Guerra Borges, I., Francisco Xavier Silva, J., Moreira Martins, J., & Xavier Silva, S. (2025). Effects of Hormonal Contraceptives on Intraocular Pressure: Implications for Patients at Risk of Glaucoma . Brazilian Journal of Implantology and Health Sciences, 7(2), 2184–2191. https://doi.org/10.36557/2674-8169.2025v7n2p2184-2191

Abstract

Introduction: Glaucoma is one of the leading causes of irreversible blindness worldwide, characterized by progressive deterioration of the optic nerve and loss of visual field. This article aims to review the current literature on the relationship between the use of hormonal contraceptives and intraocular pressure (IOP), focusing on the implications for patients at risk of developing glaucoma. Methods: The review was conducted using the databases PubMed, SciELO, and MEDLINE. Inclusion criteria encompassed studies published in the last decade that explored the association between the use of hormonal contraceptives and variations in IOP, as well as their possible implications for individuals predisposed to glaucoma. The keywords used in the search were: "intraocular pressure," "hormonal contraceptives," "glaucoma," "risk factors," and "eye health.". Results: The review highlighted that users of implant-supported full prostheses demonstrated better quality of life and satisfaction compared to those who use mucosal-supported full prostheses. Furthermore, some studies indicated that the hormones present in contraceptives may influence IOP, although the exact mechanisms are still under investigation. Conclusion: The use of hormonal contraceptives may have significant effects on IOP, especially in patients at risk of glaucoma. It is crucial for healthcare professionals, including ophthalmologists and gynecologists, to conduct continuous monitoring of IOP in patients using these contraceptives. More clinical studies are needed to deepen the understanding of this relationship and to personalize usage decisions based on risks and benefits, ensuring careful management of eye health.

https://doi.org/10.36557/2674-8169.2025v7n2p2184-2191
PDF (Português (Brasil))

References

Gillmann K, Bravetti G, Mansouri K. Effects of sex hormones on ocular blood flow and intraocular pressure in primary open-angle glaucoma: the effect of orgasm and sexual activity. J Glaucoma. 2019;28(11):1057-1062. doi: 10.1097/IJG.0000000000001175.

Fortepiani L, Foutch B, Wilson M. The effects of sex, oral contraception, and menstrual cycle phase on intraocular pressure, central corneal thickness, and foveal thickness: a descriptive analysis. Vision. 2021;5(4):48. doi: 10.3390/vision5040048.

Wang Y, Kakigi C, Barbosa D, Porco T, Chen R, Wang S, Li Y, Singh K, Pasquale L, Lin S. Oral contraceptive use and prevalence of self-reported glaucoma or ocular hypertension in the United States. Ophthalmology. 2016;123(4):729-36. doi: 10.1016/j.ophtha.2015.11.029.

Tehrani S. Gender difference in the pathophysiology and treatment of glaucoma. Curr Eye Res. 2015;40(2):191-200. doi: 10.3109/02713683.2014.968935.

Chen X, Liu Y, Zhang Y, Kam W, Pasquale L, Sullivan D. Does estrogen deficiency promote the development of glaucoma. Invest Ophthalmol Vis Sci. 2017;58(8):850.

Patel P, Harris A, Toris C, Tobe L, Lang M, Belamkar A, Ng A, Vercellin A, Mathew S, Siesky B. Effects of sex hormones on ocular blood flow and intraocular pressure in primary open-angle glaucoma: a review. J Glaucoma. 2018;27(12):1037-1041. doi: 10.1097/IJG.0000000000001106.

Nuzzi R, Scalabrin S, Becco A, Panzica G. Gonadal hormones and retinal disorders: a review. Front Endocrinol. 2018;9:66. doi: 10.3389/fendo.2018.00066.

Moschos M, Nitoda E. The impact of combined oral contraceptives on ocular tissues: a review of ocular effects. Int J Ophthalmol. 2017;10(10):1604-1610. doi: 10.18240/ijo.2017.10.19.

Bhanwra S, Ahluwalia K. The association of oral contraceptive pills with increase in intraocular pressure: time for pharmacovigilance to step in. J Pharmacol Pharmacother. 2015;6(1):51-52. doi: 10.4103/0976-500X.149150.

Tandon A, Agarwal R, Sethi S, Dabas R, Verma S, Dhingra P. Ocular complications in women using oral contraceptives. Int J Sci Res. 2018;6(1):1-4.

Dewundara S, Wiggs J, Sullivan D, Pasquale L. Is estrogen a therapeutic target for glaucoma? Semin Ophthalmol. 2016;31(2):140-146. doi: 10.3109/08820538.2015.1114845.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2025 Isadora Villamarim Guerra Borges, João Francisco Xavier Silva, Julia Moreira Martins, Sofia Xavier Silva

Downloads

Download data is not yet available.
1 1